Corporate Charity – Is The Gates Foundation Addressing Or Reinforcing Systemic Problems Raised By COVID-19? 31/10/2020 Rohit Malpani, Brook Baker & Mohga Kamal-Yanni Two competing approaches to promote access to medicines were born during the HIV/AIDS pandemic in the year 2000. Today, at the height of the COVID-19 pandemic, these same approaches are once more on a collision course. On the one side is the ‘international’ COVID response, led in name by WHO, but in fact by what […] Continue reading -> WHO’s Legal Mandate Is Weak In Responding To COVID-19 Emergency; But Changes Are Up To Member States 23/04/2020 Svĕt Lustig Vijay In the wake of the COVID-19 pandemic, there could be “a window of opportunity… that would be suicidal to miss” to revise the International Health Regulations that govern countries’ behaviour during health emergencies, said Gian Luca Burci, former World Health Organization head legal counsel and now professor of international law, at a panel hosted by […] Continue reading -> Europe’s COVID-19 Pandemic In Data – Case Counts, Mortality & Testing Rates 22/04/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher With COVID-19 pandemic curves beginning to flatten out in many parts of the Europe, Health Policy Watch presents a snapshot of infection and death trends in WHO’s European region through graphs that tell the story, using up-to-date data from the COVID-19 tracker of the Geneva-based Foundation for Innovative New Diagnostics (FIND). Notably, some striking, but […] Continue reading -> Access To Affordable Biologics In The Context Of COVID-19: Will WHO Step Up To Its Responsibility? 14/04/2020 Chetali Rao & K M Gopakumar New Delhi, India – COVID-19 has posed unique challenges for healthcare providers across the globe, as the world has been grappling with the pandemic with no approved treatments or vaccines for the disease. Researchers are searching everywhere for drugs that may help treat or prevent the spread of the deadly virus. This has led to […] Continue reading -> COVID-19 Testing Trends – Globally & Regionally 30/03/2020 Svĕt Lustig Vijay Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Testing: the crux of effective outbreak responses Testing is an essential component of effective outbreak responses. Without widespread testing, we cannot know whether a disease is spreading nor take measures to appropriately respond to it. “All countries should be able to test all suspected cases, they cannot fight this pandemic blindfolded, they should know where […] Continue reading -> How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> Explore “Health: A Political Choice” – A New Publication On Delivering UHC 27/06/2019 Editorial team Click here, or on the image below, to explore the new publication. Continue reading -> Explore “Antibiotic Footprint” Of Countries Worldwide In Online Tool 18/06/2019 Editorial team AntibioticFootprint.net details the “antibiotic footprint” of countries worldwide, based on available, official data for health and agriculture sectors. Click here or on the image below to explore the online tool. Image Credits: AntibioticFootprint.net. Continue reading -> Knowledge Portal On Innovation And Access To Medicines 14/06/2019 Editorial team Click here or on the image below to be redirected to the Knowledge Portal. Continue reading -> Posts navigation Newer posts
WHO’s Legal Mandate Is Weak In Responding To COVID-19 Emergency; But Changes Are Up To Member States 23/04/2020 Svĕt Lustig Vijay In the wake of the COVID-19 pandemic, there could be “a window of opportunity… that would be suicidal to miss” to revise the International Health Regulations that govern countries’ behaviour during health emergencies, said Gian Luca Burci, former World Health Organization head legal counsel and now professor of international law, at a panel hosted by […] Continue reading -> Europe’s COVID-19 Pandemic In Data – Case Counts, Mortality & Testing Rates 22/04/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher With COVID-19 pandemic curves beginning to flatten out in many parts of the Europe, Health Policy Watch presents a snapshot of infection and death trends in WHO’s European region through graphs that tell the story, using up-to-date data from the COVID-19 tracker of the Geneva-based Foundation for Innovative New Diagnostics (FIND). Notably, some striking, but […] Continue reading -> Access To Affordable Biologics In The Context Of COVID-19: Will WHO Step Up To Its Responsibility? 14/04/2020 Chetali Rao & K M Gopakumar New Delhi, India – COVID-19 has posed unique challenges for healthcare providers across the globe, as the world has been grappling with the pandemic with no approved treatments or vaccines for the disease. Researchers are searching everywhere for drugs that may help treat or prevent the spread of the deadly virus. This has led to […] Continue reading -> COVID-19 Testing Trends – Globally & Regionally 30/03/2020 Svĕt Lustig Vijay Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Testing: the crux of effective outbreak responses Testing is an essential component of effective outbreak responses. Without widespread testing, we cannot know whether a disease is spreading nor take measures to appropriately respond to it. “All countries should be able to test all suspected cases, they cannot fight this pandemic blindfolded, they should know where […] Continue reading -> How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> Explore “Health: A Political Choice” – A New Publication On Delivering UHC 27/06/2019 Editorial team Click here, or on the image below, to explore the new publication. Continue reading -> Explore “Antibiotic Footprint” Of Countries Worldwide In Online Tool 18/06/2019 Editorial team AntibioticFootprint.net details the “antibiotic footprint” of countries worldwide, based on available, official data for health and agriculture sectors. Click here or on the image below to explore the online tool. Image Credits: AntibioticFootprint.net. Continue reading -> Knowledge Portal On Innovation And Access To Medicines 14/06/2019 Editorial team Click here or on the image below to be redirected to the Knowledge Portal. Continue reading -> Posts navigation Newer posts
Europe’s COVID-19 Pandemic In Data – Case Counts, Mortality & Testing Rates 22/04/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher With COVID-19 pandemic curves beginning to flatten out in many parts of the Europe, Health Policy Watch presents a snapshot of infection and death trends in WHO’s European region through graphs that tell the story, using up-to-date data from the COVID-19 tracker of the Geneva-based Foundation for Innovative New Diagnostics (FIND). Notably, some striking, but […] Continue reading -> Access To Affordable Biologics In The Context Of COVID-19: Will WHO Step Up To Its Responsibility? 14/04/2020 Chetali Rao & K M Gopakumar New Delhi, India – COVID-19 has posed unique challenges for healthcare providers across the globe, as the world has been grappling with the pandemic with no approved treatments or vaccines for the disease. Researchers are searching everywhere for drugs that may help treat or prevent the spread of the deadly virus. This has led to […] Continue reading -> COVID-19 Testing Trends – Globally & Regionally 30/03/2020 Svĕt Lustig Vijay Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Testing: the crux of effective outbreak responses Testing is an essential component of effective outbreak responses. Without widespread testing, we cannot know whether a disease is spreading nor take measures to appropriately respond to it. “All countries should be able to test all suspected cases, they cannot fight this pandemic blindfolded, they should know where […] Continue reading -> How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> Explore “Health: A Political Choice” – A New Publication On Delivering UHC 27/06/2019 Editorial team Click here, or on the image below, to explore the new publication. Continue reading -> Explore “Antibiotic Footprint” Of Countries Worldwide In Online Tool 18/06/2019 Editorial team AntibioticFootprint.net details the “antibiotic footprint” of countries worldwide, based on available, official data for health and agriculture sectors. Click here or on the image below to explore the online tool. Image Credits: AntibioticFootprint.net. Continue reading -> Knowledge Portal On Innovation And Access To Medicines 14/06/2019 Editorial team Click here or on the image below to be redirected to the Knowledge Portal. Continue reading -> Posts navigation Newer posts
Access To Affordable Biologics In The Context Of COVID-19: Will WHO Step Up To Its Responsibility? 14/04/2020 Chetali Rao & K M Gopakumar New Delhi, India – COVID-19 has posed unique challenges for healthcare providers across the globe, as the world has been grappling with the pandemic with no approved treatments or vaccines for the disease. Researchers are searching everywhere for drugs that may help treat or prevent the spread of the deadly virus. This has led to […] Continue reading -> COVID-19 Testing Trends – Globally & Regionally 30/03/2020 Svĕt Lustig Vijay Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Testing: the crux of effective outbreak responses Testing is an essential component of effective outbreak responses. Without widespread testing, we cannot know whether a disease is spreading nor take measures to appropriately respond to it. “All countries should be able to test all suspected cases, they cannot fight this pandemic blindfolded, they should know where […] Continue reading -> How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> Explore “Health: A Political Choice” – A New Publication On Delivering UHC 27/06/2019 Editorial team Click here, or on the image below, to explore the new publication. Continue reading -> Explore “Antibiotic Footprint” Of Countries Worldwide In Online Tool 18/06/2019 Editorial team AntibioticFootprint.net details the “antibiotic footprint” of countries worldwide, based on available, official data for health and agriculture sectors. Click here or on the image below to explore the online tool. Image Credits: AntibioticFootprint.net. Continue reading -> Knowledge Portal On Innovation And Access To Medicines 14/06/2019 Editorial team Click here or on the image below to be redirected to the Knowledge Portal. Continue reading -> Posts navigation Newer posts
COVID-19 Testing Trends – Globally & Regionally 30/03/2020 Svĕt Lustig Vijay Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 Testing: the crux of effective outbreak responses Testing is an essential component of effective outbreak responses. Without widespread testing, we cannot know whether a disease is spreading nor take measures to appropriately respond to it. “All countries should be able to test all suspected cases, they cannot fight this pandemic blindfolded, they should know where […] Continue reading -> How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> Explore “Health: A Political Choice” – A New Publication On Delivering UHC 27/06/2019 Editorial team Click here, or on the image below, to explore the new publication. Continue reading -> Explore “Antibiotic Footprint” Of Countries Worldwide In Online Tool 18/06/2019 Editorial team AntibioticFootprint.net details the “antibiotic footprint” of countries worldwide, based on available, official data for health and agriculture sectors. Click here or on the image below to explore the online tool. Image Credits: AntibioticFootprint.net. Continue reading -> Knowledge Portal On Innovation And Access To Medicines 14/06/2019 Editorial team Click here or on the image below to be redirected to the Knowledge Portal. Continue reading -> Posts navigation Newer posts
How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> Explore “Health: A Political Choice” – A New Publication On Delivering UHC 27/06/2019 Editorial team Click here, or on the image below, to explore the new publication. Continue reading -> Explore “Antibiotic Footprint” Of Countries Worldwide In Online Tool 18/06/2019 Editorial team AntibioticFootprint.net details the “antibiotic footprint” of countries worldwide, based on available, official data for health and agriculture sectors. Click here or on the image below to explore the online tool. Image Credits: AntibioticFootprint.net. Continue reading -> Knowledge Portal On Innovation And Access To Medicines 14/06/2019 Editorial team Click here or on the image below to be redirected to the Knowledge Portal. Continue reading -> Posts navigation Newer posts
WHO’s New Essential Medicines List: CEO Of Patients’ Alliance Shares Views 10/07/2019 Guest contributor Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO), answers 5 questions on why the Essential Medicines List is important for patients. IAPO is a United Kingdom-based alliance of 276 member organisations from 71 countries representing 50 disease areas, and working in collaboration with civil society, UN agencies and the healthcare industry. Sehmi holds a […] Continue reading -> Explore “Health: A Political Choice” – A New Publication On Delivering UHC 27/06/2019 Editorial team Click here, or on the image below, to explore the new publication. Continue reading -> Explore “Antibiotic Footprint” Of Countries Worldwide In Online Tool 18/06/2019 Editorial team AntibioticFootprint.net details the “antibiotic footprint” of countries worldwide, based on available, official data for health and agriculture sectors. Click here or on the image below to explore the online tool. Image Credits: AntibioticFootprint.net. Continue reading -> Knowledge Portal On Innovation And Access To Medicines 14/06/2019 Editorial team Click here or on the image below to be redirected to the Knowledge Portal. Continue reading -> Posts navigation Newer posts
Explore “Health: A Political Choice” – A New Publication On Delivering UHC 27/06/2019 Editorial team Click here, or on the image below, to explore the new publication. Continue reading -> Explore “Antibiotic Footprint” Of Countries Worldwide In Online Tool 18/06/2019 Editorial team AntibioticFootprint.net details the “antibiotic footprint” of countries worldwide, based on available, official data for health and agriculture sectors. Click here or on the image below to explore the online tool. Image Credits: AntibioticFootprint.net. Continue reading -> Knowledge Portal On Innovation And Access To Medicines 14/06/2019 Editorial team Click here or on the image below to be redirected to the Knowledge Portal. Continue reading -> Posts navigation Newer posts
Explore “Antibiotic Footprint” Of Countries Worldwide In Online Tool 18/06/2019 Editorial team AntibioticFootprint.net details the “antibiotic footprint” of countries worldwide, based on available, official data for health and agriculture sectors. Click here or on the image below to explore the online tool. Image Credits: AntibioticFootprint.net. Continue reading -> Knowledge Portal On Innovation And Access To Medicines 14/06/2019 Editorial team Click here or on the image below to be redirected to the Knowledge Portal. Continue reading -> Posts navigation Newer posts
Knowledge Portal On Innovation And Access To Medicines 14/06/2019 Editorial team Click here or on the image below to be redirected to the Knowledge Portal. Continue reading -> Posts navigation Newer posts